| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Dez―22 |
Selection of SAS-Tolerant Microorganisms from Activated Sludge and Assessment of Biodegradation Potential of SARS-CoV-2 Antivirals by Pure Bacterial Cultures and Activated Sludge |
Dora Lastovčić, Martina Miloloža Nikolić, Ivona Zirn, Marinko Markić, Tomislav Bolanča, Šime Ukić, Dajana Kučić Grgić |
| 2 |
[GO] |
2024―Nov―22 |
Body Volatilome Study Strategy for COVID-19 Biomarker Identification Considering Exogenous Parameters |
Elsa Boudard, Nabil Moumane, José Dugay, Jérôme Vial, Didier Thiébaut |
| 3 |
[GO] |
2023―Jan―23 |
Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication |
Kateřina Veselá, Zora Mělková, Nikita Abramenko, Zdeněk Kejík, Robert Kaplánek, Petr Dytrych, et al. (+4) Alla Sinica, Oleksandra Vozniuk, Pavel Martásek, Milan Jakubek |
| 4 |
[GO] |
2022―Okt―12 |
Development and Validation of HPLC-DAD Method for the Determination of Favirapir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favirapir |
Mohammad Hailat, Israa Al-Ani, Zainab Zakareia, Ramadan Al-Shdefat, Osaid Al-Meanazel, Md. Khalid Anwer, et al. (+4) Mohammed Hamad, Walid Abu Rayyan, Riad Awad, Wael Abu Dayyih |
| 5 |
[GO] |
2021―Okt―18 |
Separation and Disinfection of Contagious Aerosols from the Perspective of SARS-CoV-2 |
J. J. H. Brouwers |
|
